Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADIL Adial Pharmaceuticals

Post-Mkt 09-14 16:23:21 EDT

5.00

+0.10

+2.04%

盘后5.00

+0.000.00%

16:10 EDT

High5.18	Low4.87	Vol46.52K
Open4.94	D1 Closing4.90	Amplitude6.33%
Mkt Cap13.13M	Tradable Cap10.65M	Total Shares2.63M
T/O233.66K	T/O Rate2.18%	Tradable Shares2.13M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADIL","market":"US","secType":"STK","nameCN":"Adial Pharmaceuticals","latestPrice":5,"timestamp":1789416000000,"preClose":4.9,"halted":0,"volume":46518,"hourTrading":{"tag":"盘后","latestPrice":5,"preClose":5,"latestTime":"16:10 EDT","volume":46,"amount":230,"timestamp":1789416603325,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.020408163265306048,"floatShares":2129800,"shares":2625900,"eps":-17.71,"marketStatus":"Post-Mkt","change":0.1,"latestTime":"09-14 16:23:21 EDT","open":4.94,"high":5.18,"low":4.87,"amount":233658,"amplitude":0.063265,"askPrice":5.07,"askSize":5,"bidPrice":4.39,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-17.71,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789430400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1532664000000,"exchange":"NASDAQ","adjPreClose":4.9,"preHourTrading":{"tag":"盘前","latestPrice":5,"preClose":4.9,"latestTime":"09:21 EDT","volume":5,"amount":25,"timestamp":1789392115689,"change":0.1,"changeRate":0.020408,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5,"preClose":5,"latestTime":"16:10 EDT","volume":46,"amount":230,"timestamp":1789416603325,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.795762,"impliedVol":1.6275,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ADIL/wiki","defaultTab":"wiki","newsList":[{"id":"2663401562","title":"Adial Pharmaceuticals files to sell 25.15M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2663401562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663401562?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:55","pubTimestamp":1787950509,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 25.15M shares of common stock. The company is not ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-files-to-sell-25-15m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-files-to-sell-25-15m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663515015","title":"Adial Pharmaceuticals - Proposed Resale of up to 25,148,970 Shares of Common Stock by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2663515015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663515015?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:49","pubTimestamp":1787950189,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P1U1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662799054","title":"Adial Pharma Grants Unregistered Option for 307,814 Shares at $5.76 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662799054","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662799054?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:05","pubTimestamp":1787735130,"startTime":"0","endTime":"0","summary":"Adial Pharma grants unregistered option for 307,814 shares at $5.76 per shareAdial granted an unregistered inducement stock option for 307,814 common shares to a new employee on Aug. 19, 2026.Exercise price USD 5.76 per share; 10-year term.Vesting over four years: 25% after one year; remainder monthly, subject to continued service.Issued outside equity plans under Nasdaq Rule 5635; relying on Securities Act Section 4 and Regulation D.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 25, 2026, and is solely resp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7c9BTj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662788752","title":"Adial Pharmaceuticals Grants Inducement Stock Options to New Hire","url":"https://stock-news.laohu8.com/highlight/detail?id=2662788752","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662788752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:57","pubTimestamp":1787691450,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals ( ($ADIL) ) just unveiled an update. On August 19, 2026, Adial Pharmaceuticals granted a stock option to purchase 307,814 sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-grants-inducement-stock-options-to-new-hire?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-grants-inducement-stock-options-to-new-hire?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662754923","title":"Adial Pharmaceuticals Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662754923","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662754923?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:05","pubTimestamp":1787688301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA3NMPF6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662440754","title":"Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662440754","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662440754?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:05","pubTimestamp":1787688300,"startTime":"0","endTime":"0","summary":"GLEN ALLEN, Va., Aug.  25, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee has granted a new em","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350874/0/en/adial-pharmaceuticals-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662812206","title":"Adial Pharmaceuticals Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2662812206","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662812206?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:07","pubTimestamp":1787602045,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals announces annual shareholder meetingAdial Pharmaceuticals will hold its annual stockholder meeting in Charlottesville, Virginia on Sept. 17, 2026.Votes include electing two Class","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL7Pw04F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661218965","title":"Adial Pharmaceuticals Faces Nasdaq Listing Compliance Challenge","url":"https://stock-news.laohu8.com/highlight/detail?id=2661218965","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661218965?lang=en_us&edition=fundamental","pubTime":"2026-08-22 06:02","pubTimestamp":1787349724,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Adial Pharmaceuticals ( ($ADIL) ). On August 18, 2026, Adial Pharmaceuticals received a notice from Nasdaq that...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-faces-nasdaq-listing-compliance-challenge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-faces-nasdaq-listing-compliance-challenge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","LCLG","ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290167","title":"Adial Pharmaceuticals Gets NASDAQ Notice for Falling Below $2.5 Million Stockholders’ Equity Minimum","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290167","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290167?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:18","pubTimestamp":1787347115,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals gets Nasdaq notice for falling below $2.5 million stockholders’ equity minimumAdial Pharmaceuticals received a Nasdaq notice on Aug. 18, 2026 for falling below the $2.5 million m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL1H34pT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660717436","title":"U.S. Stocks on the MOVE - Sunrun, JetBlue Airways, Dell Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2660717436","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660717436?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:52","pubTimestamp":1786981972,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell TechnologiesAug 17 (Reuters)-The S&P 500 was muted on Monday as markets weighed tensions between the U.S. and Iran, while the report of a s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL6N44E0P9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4615","BRBS","LU0314106906.USD","SMHX","BK4588","ADIL","OABI","LHX","BK4602","CNAV","KBR","LABX","IE00BLSP4452.SGD","CNC","JBLU","SOXY","FTH","YSS","FSPC","GNL","LU0477156797.USD","LUNR","LU0162691827.USD","BK4154","LUNL","ALM","LU1699723380.USD","CNCG","CHAT","XTN","COWG","DT","WDGF","XSD","IE00BN8TJ469.HKD","FULC","SPRX","TAN","EYPT","ALAB","LU0072461881.USD","HTB","LU2265009873.SGD","WSPC","MAIR","LU1506573853.SGD","IE0034235188.USD","LU2362541513.USD","RUN","AIPI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660381054","title":"U.S. Stocks on the MOVE - KBR, Vista Energy, Fulcrum Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2660381054","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660381054?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:29","pubTimestamp":1786973346,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE - KBR, Vista Energy, Fulcrum TherapeuticsAug 17 (Reuters)-The S&P 500 was set to open subdued on Monday as markets weighed the prospect of fewer interest-rate hikes agains","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4N44E0X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","YSS","BK4123","SGXZ23171101.USD","ADIL","GNL","SG9999004303.SGD","LU2362541513.USD","BK4007","BK4160","LU2362540622.SGD","KBR","LU2362541273.HKD","BK4121","FULC","BK4187","OABI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482788","title":"Adial Pharmaceuticals Q2 EPS $(11.25)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482788","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482788?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:00","pubTimestamp":1786968017,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals Q2 EPS $(11.25)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/ADIL","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660589482","title":"Adial Pharmaceuticals Falls After Quarterly Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2660589482","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660589482?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:38","pubTimestamp":1786966684,"startTime":"0","endTime":"0","summary":"BUZZ-Adial Pharmaceuticals falls after quarterly loss widens** Shares of drug developer Adial PharmaceuticalsADIL.Ofall 22.6% to $3.08 premarket** Co's Q2 loss widens to $11.25 per share from $4.61 a ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4N44E0OV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660844414","title":"Adial Pharmaceuticals Posts Bigger-than-Expected Q2 Net Loss, Hurt by Acquisition Charges","url":"https://stock-news.laohu8.com/highlight/detail?id=2660844414","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660844414?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:14","pubTimestamp":1786965280,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals posts bigger-than-expected Q2 net loss, hurt by acquisition chargesOverviewUS biopharmaceutical firm's Q2 net loss widened, coming below analyst expectationsQ2 loss per share cam","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL1N44E09V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE","ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484353","title":"Adial Pharmaceuticals Q2 Net Income USD -52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484353","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484353?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:00","pubTimestamp":1786964402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXLV9FKM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660809484","title":"Press Release: Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2660809484","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660809484?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:00","pubTimestamp":1786964400,"startTime":"0","endTime":"0","summary":"compared to $4.6 million as of March 31, 2026. The Company believes that. its existing cash and cash equivalents will fund its operating expenses. into the second half of 2027. This does not assume receipt of the. additional $32 million available under the milestone tranche of the","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660891784","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2660891784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660891784?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:00","pubTimestamp":1786960800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·Amer Sports Inc.                                  2Q       .11    6:00 AM. ·Home Depot Inc.                                   2Q      4.73    6:00 AM. ·Pony AI ADR                                     2Q      (.15)   5:00 AM. ·BILL Hldgs Inc                                  4Q       .71    4:01 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAP","CAAP","HAIN","BEEM","AS","BJ","BABA","DCGO","ANF","DOMO","ANVS","ATHM","COTY","HD","XP","HTHT","GGAL","LOW","BIDU","CNSY","LYTS","ALVO","MRCY","LONA","BEKE","IQ","MBRX","NDSN","IMTX","FBRX","BMA","EL","FLO","ADI","ATAT","FLUX","ADIL","ZTO","MRKR","KEYS","KLAR","JKHY","KC","FN","FUTU","HSAI","BILL","LZB","FLNG","DE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659765171","title":"Adial Pharma Faces Governance Risks and Major Dilution as 2026 Shareholder Vote Looms on Preferred Conversions and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2659765171","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659765171?lang=en_us&edition=fundamental","pubTime":"2026-08-16 14:00","pubTimestamp":1786860052,"startTime":"0","endTime":"0","summary":"Adial Pharma (ADIL) has disclosed a new risk, in the Share Price & Shareholder Rights category. Adial Pharma faces a governance and financing risk ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharma-faces-governance-risks-and-major-dilution-as-2026-shareholder-vote-looms-on-preferred-conversions-and-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharma-faces-governance-risks-and-major-dilution-as-2026-shareholder-vote-looms-on-preferred-conversions-and-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121411","title":"Adial Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121411","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121411?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:02","pubTimestamp":1786741379,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings SummaryAdial Pharmaceuticals IncADIL.OQreported a quarterly adjusted loss of $11.25 per share for the quarter ended J","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B1LP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659612938","title":"Adial Q2 Net Loss Widens to $51.99 Million from Year-Ago Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2659612938","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659612938?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:14","pubTimestamp":1786738497,"startTime":"0","endTime":"0","summary":"Adial Q2 net loss widens to $51.99 million from year-ago quarterAdial posted a GAAP net loss of USD 51.99 million for the quarter ended June 30, 2026, versus a USD 1.96 million loss a year earlier.Ope","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL23Vw2Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adial.com","stockEarnings":[{"period":"1week","weight":-0.3118},{"period":"1month","weight":0.1369},{"period":"3month","weight":0.6443},{"period":"6month","weight":1.5},{"period":"1year","weight":-0.4441},{"period":"ytd","weight":-0.1091}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.058856},{"month":2,"riseRate":0.25,"avgChangeRate":-0.031808},{"month":3,"riseRate":0,"avgChangeRate":-0.155549},{"month":4,"riseRate":0.375,"avgChangeRate":-0.03424},{"month":5,"riseRate":0.375,"avgChangeRate":-0.002623},{"month":6,"riseRate":0.375,"avgChangeRate":-0.130351},{"month":7,"riseRate":0.625,"avgChangeRate":0.108193},{"month":8,"riseRate":0.222222,"avgChangeRate":0.014777},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.050169},{"month":10,"riseRate":0.25,"avgChangeRate":-0.152838},{"month":11,"riseRate":0.375,"avgChangeRate":0.139286},{"month":12,"riseRate":0.375,"avgChangeRate":0.00671}],"exchange":"NASDAQ","name":"Adial Pharmaceuticals","nameEN":"Adial Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Adial Pharmaceuticals(ADIL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Adial Pharmaceuticals,ADIL,Adial Pharmaceuticals股票,Adial Pharmaceuticals股票老虎,Adial Pharmaceuticals股票老虎国际,Adial Pharmaceuticals行情,Adial Pharmaceuticals股票行情,Adial Pharmaceuticals股价,Adial Pharmaceuticals股市,Adial Pharmaceuticals股票价格,Adial Pharmaceuticals股票交易,Adial Pharmaceuticals股票购买,Adial Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Adial Pharmaceuticals(ADIL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction